Microbot Medical Inc(MBOT)stock report

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company’s TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.

Finance:
Market Cap:47.8M; Shares Outstanding:4.3M; Q3 2019(9/30/19): Cash 6.05M. Loss 1.88M

EPS and Sales:
https://finance.yahoo.com/quote/MBOT/financials?p=MBOT

Date EPS % last year % last quarter
2018.12.31 -2.41 12.68% -34.64%
2019.3.31 -0.48 4.00% 80.08%
2019.6.30 -0.83 30.83% -72.92%
2019.9.30 -1.27 29.05% -53.01%

 

Insider Transactions:
http://insidercow.com/history/company.jsp?company=MBOT&B1=Search%21

Institution Ownership:
https://www.marketbeat.com/stocks/NYSE/MBOT/institutional-ownership/

2019.12.29:
Total institutions: 34,no change
Shares hold: 613.6k shares. no change
shares% hold: 14.24%,no change

Analyst Ratings:
https://www.tipranks.com/stocks/MBOT/price-targe

Leave a Reply